Exact Mass: 670.4960836
Exact Mass Matches: 670.4960836
Found 500 metabolites which its exact mass value is equals to given mass value 670.4960836,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
PA(14:0/20:3(5Z,8Z,11Z))
PA(14:0/20:3(5Z,8Z,11Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:0/20:3(5Z,8Z,11Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of mead acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(16:0/18:3(6Z,9Z,12Z))
PA(16:0/18:3(6Z,9Z,12Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of gamma-linolenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(16:0/18:3(9Z,12Z,15Z))
PA(16:0/18:3(9Z,12Z,15Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:0/18:3(9Z,12Z,15Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of alpha-linolenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(16:1(9Z)/18:2(9Z,12Z))
PA(16:1(9Z)/18:2(9Z,12Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:1(9Z)/18:2(9Z,12Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of linoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(18:2(9Z,12Z)/16:1(9Z))
PA(18:2(9Z,12Z)/16:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:2(9Z,12Z)/16:1(9Z)), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(18:3(6Z,9Z,12Z)/16:0)
PA(18:3(6Z,9Z,12Z)/16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:3(6Z,9Z,12Z)/16:0), in particular, consists of one chain of gamma-linolenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(18:3(9Z,12Z,15Z)/16:0)
PA(18:3(9Z,12Z,15Z)/16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:3(9Z,12Z,15Z)/16:0), in particular, consists of one chain of alpha-linolenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(20:3(5Z,8Z,11Z)/14:0)
PA(20:3(5Z,8Z,11Z)/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:3(5Z,8Z,11Z)/14:0), in particular, consists of one chain of mead acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(14:0/20:3(8Z,11Z,14Z))
PA(14:0/20:3(8Z,11Z,14Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:0/20:3(8Z,11Z,14Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of dihomo-gamma-linolenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(14:1(9Z)/20:2(11Z,14Z))
PA(14:1(9Z)/20:2(11Z,14Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:1(9Z)/20:2(11Z,14Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(20:2(11Z,14Z)/14:1(9Z))
PA(20:2(11Z,14Z)/14:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:2(11Z,14Z)/14:1(9Z)), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(20:3(8Z,11Z,14Z)/14:0)
PA(20:3(8Z,11Z,14Z)/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:3(8Z,11Z,14Z)/14:0), in particular, consists of one chain of dihomo-gamma-linolenic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(P-16:0/18:2(10E,12Z)+=O(9))
PA(P-16:0/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(P-16:0/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one 1Z-hexadecenyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:2(10E,12Z)+=O(9)/P-16:0)
PA(18:2(10E,12Z)+=O(9)/P-16:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(10E,12Z)+=O(9)/P-16:0), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of 1Z-hexadecenyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(P-16:0/18:2(9Z,11E)+=O(13))
PA(P-16:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(P-16:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one 1Z-hexadecenyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:2(9Z,11E)+=O(13)/P-16:0)
PA(18:2(9Z,11E)+=O(13)/P-16:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(9Z,11E)+=O(13)/P-16:0), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of 1Z-hexadecenyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(P-16:0/18:3(10,12,15)-OH(9))
PA(P-16:0/18:3(10,12,15)-OH(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(P-16:0/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one 1Z-hexadecenyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:3(10,12,15)-OH(9)/P-16:0)
PA(18:3(10,12,15)-OH(9)/P-16:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(10,12,15)-OH(9)/P-16:0), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of 1Z-hexadecenyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(P-16:0/18:3(9,11,15)-OH(13))
PA(P-16:0/18:3(9,11,15)-OH(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(P-16:0/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one 1Z-hexadecenyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:3(9,11,15)-OH(13)/P-16:0)
PA(18:3(9,11,15)-OH(13)/P-16:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(9,11,15)-OH(13)/P-16:0), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of 1Z-hexadecenyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
DG(17:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)
DG(17:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/17:0/0:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(17:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))
DG(17:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/17:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(17:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)
DG(17:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/17:0/0:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(17:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))
DG(17:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/17:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(17:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)
DG(17:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/17:0/0:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(17:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))
DG(17:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/17:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(17:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)
DG(17:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/17:0/0:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(17:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))
DG(17:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/17:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(17:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)
DG(17:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/17:0/0:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(17:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))
DG(17:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/17:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)
DG(a-17:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/a-17:0/0:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))
DG(a-17:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/a-17:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)
DG(a-17:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/a-17:0/0:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))
DG(a-17:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/a-17:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)
DG(a-17:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/a-17:0/0:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))
DG(a-17:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/a-17:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)
DG(a-17:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/a-17:0/0:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))
DG(a-17:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/a-17:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)
DG(a-17:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/a-17:0/0:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))
DG(a-17:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/a-17:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)
DG(i-17:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-17:0/0:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))
DG(i-17:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/i-17:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)
DG(i-17:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-17:0/0:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))
DG(i-17:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/i-17:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)
DG(i-17:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-17:0/0:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))
DG(i-17:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/i-17:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)
DG(i-17:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-17:0/0:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))
DG(i-17:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/i-17:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)
DG(i-17:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-17:0/0:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))
DG(i-17:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/i-17:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Inostamycin C
19-Hexanoyloxymytiloxanthin
[(2R)-2-[(E)-hexadec-4-enoyl]oxy-3-phosphonooxypropyl] (9Z,12Z)-octadeca-9,12-dienoate
1-(9Z)-octadecenoyl-2-(9Z)-hexadecenoyl-sn-glycero-3-phosphate(2-)
[(8E,12E,16E)-3,4-dihydroxy-2-[[(Z)-tridec-9-enoyl]amino]octadeca-8,12,16-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E,12E)-2-(butanoylamino)-3-hydroxyoctacosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxypentacosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)tetracosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxyhexacosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-2-acetamido-3-hydroxytriaconta-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)nonacosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)tricosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)heptacosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-2-(decanoylamino)-3-hydroxydocosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)henicosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxypentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
(2-nonanoyloxy-3-octanoyloxypropyl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
(3-octanoyloxy-2-tridecanoyloxypropyl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
(2-decanoyloxy-3-nonanoyloxypropyl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
[3-octanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[3-nonanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(3-octanoyloxy-2-undecanoyloxypropyl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
(2-dodecanoyloxy-3-nonanoyloxypropyl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
(3-decanoyloxy-2-undecanoyloxypropyl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[3-decanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate
[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate
[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate
[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate
[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate
[1-[(Z)-tridec-9-enoyl]oxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-pentadec-9-enoate
[1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
[1-dodecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[2-[(Z)-tetradec-9-enoyl]oxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (Z)-tetradec-9-enoate
[1-decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
[3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-3-hydroxy-2-(octadecanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-2-(hexadecanoylamino)-3-hydroxyhexadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-2-(dodecanoylamino)-3-hydroxyicosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-3-hydroxy-2-(tetradecanoylamino)octadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-3-hydroxy-2-(tridecanoylamino)nonadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-2-(heptadecanoylamino)-3-hydroxypentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E,12E)-3-hydroxy-2-(pentadecanoylamino)heptadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]octadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]heptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-tridecanoyloxypropyl] (7Z,9Z)-tetradeca-7,9-dienoate
[3-[(Z)-dodec-5-enoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (5Z,8Z,11Z)-tetradeca-5,8,11-trienoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (7Z,9Z)-tetradeca-7,9-dienoate
[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] pentadecanoate
2,3-bis[[(Z)-dodec-5-enoyl]oxy]propyl (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate
[2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] (Z)-pentadec-9-enoate
2,3-bis[[(6Z,9Z)-dodeca-6,9-dienoyl]oxy]propyl (Z)-pentadec-9-enoate
[(E)-3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (Z)-tetradec-9-enoate
[(4E,8E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-dodecanoyloxypropyl] (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate
[3-dodecanoyloxy-2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate
[(E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-tridecanoyloxypropyl] (5Z,8Z,11Z)-tetradeca-5,8,11-trienoate
[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate
[(4E,8E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(2S,3R,4E,6E)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxypentadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[(E,2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]tetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(2S)-1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate
[(2R)-2-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (9E,12E)-octadeca-9,12-dienoate
[1-carboxy-3-[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[(2R)-2-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (6E,9E)-octadeca-6,9-dienoate
[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[(2R)-2-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (9E,11E)-octadeca-9,11-dienoate
[(2S)-1-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (6E,9E)-octadeca-6,9-dienoate
[(2S,3R,4E,6E)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyhexadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(2S,3R,4E,6E)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]tetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[1-carboxy-3-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[(2R)-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-undecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate
[1-dodecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate
[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[1-carboxy-3-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[(2S)-1-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9E,11E)-octadeca-9,11-dienoate
[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[(2S)-2-[(E)-tetradec-9-enoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-tetradec-9-enoate
[(2S,3R,4E,8E)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[1-carboxy-3-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[(2S)-1-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (2E,4E)-octadeca-2,4-dienoate
[(2R)-2-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (2E,4E)-octadeca-2,4-dienoate
[(2S)-1-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate
[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
[(2S,3R,4E,8E)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxypentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[(E,2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C37H71N2O6P (670.5049475999999)
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]propyl]-trimethylazanium
C40H64NO7+ (670.4682533999999)
2-[hydroxy-[3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]-2-nonanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
2-[hydroxy-[3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
2-[[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-2-heptanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
2-[carboxy-[2-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
C40H64NO7+ (670.4682533999999)
2-[carboxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-nonanoyloxypropoxy]methoxy]ethyl-trimethylazanium
2-[carboxy-[3-pentadecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
2-[carboxy-[3-decanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
2-[carboxy-[2-[(Z)-pentadec-9-enoyl]oxy-3-tridecanoyloxypropoxy]methoxy]ethyl-trimethylazanium
2-[carboxy-[3-dodecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
2-[carboxy-[2-[(Z)-heptadec-9-enoyl]oxy-3-undecanoyloxypropoxy]methoxy]ethyl-trimethylazanium
2-[carboxy-[3-tetradecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
2-[hydroxy-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-nonoxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
2-[carboxy-[2-[(Z)-icos-11-enoyl]oxy-3-octanoyloxypropoxy]methoxy]ethyl-trimethylazanium
2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
2-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-tridecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
2-[hydroxy-[2-pentanoyloxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
2-[hydroxy-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-undecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
2-[[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
2-[[3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C37H69NO7P+ (670.4811393999998)
TG(39:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MGDG(28:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
SM(32:3)
C37H71N2O6P (670.5049475999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMePA(33:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PMe(34:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved